Alnylam Pharmaceuticals, Inc. (LON:0HD2)

Alnylam Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-278.16	-440.24	-1,131	-852.82	-858.28
Depreciation & Amortization	56.67	54.05	44.47	89.69	74.44
Loss (Gain) From Sale of Investments	3.02	16.94	33.31	-55.7	-54.04
Stock-Based Compensation	272.08	221.68	230.65	165.72	139.87
Other Operating Activities	152.15	194.46	273.84	174.24	95.76
Change in Accounts Receivable	-86.55	-87.94	-45.6	-101.8	-56.24
Change in Inventory	13.59	18.37	-34.14	-26.42	-35.43
Change in Accounts Payable	91.09	80.84	191.77	88.24	143.73
Change in Unearned Revenue	-235.45	55.02	-65.91	-50.4	-43.97
Change in Other Net Operating Assets	3.23	-9.03	-38.51	-72.45	-20.81
Operating Cash Flow	-8.31	104.16	-541.27	-641.69	-614.96
Capital Expenditures	-34.28	-62.21	-72.06	-76.37	-70.36
Investment in Securities	-63.25	-269.7	254.61	-192.56	-333.96
Other Investing Activities	-19.32	-4.44	-13.19	-4.36	-31.2
Investing Cash Flow	-116.84	-336.35	169.35	-273.3	-435.52
Long-Term Debt Issued	-	-	1,016	500	200
Long-Term Debt Repaid	-	-	-880.72	-	-
Net Debt Issued (Repaid)	-	-	135.39	500	200
Issuance of Common Stock	302.95	147.46	259.36	246.27	299.98
Other Financing Activities	-8.79	24.67	31	500.85	495
Financing Cash Flow	294.16	172.13	425.75	1,247	994.98
Foreign Exchange Rate Adjustments	-15.24	6.39	-7.43	-9.02	4.92
Net Cash Flow	153.77	-53.67	46.4	323.11	-50.58
Free Cash Flow	-42.59	41.95	-613.33	-718.07	-685.32
Free Cash Flow Margin	-1.89%	2.29%	-59.12%	-85.05%	-139.05%
Free Cash Flow Per Share	-0.33	0.34	-5.04	-6.06	-5.96
Cash Interest Paid	67.58	32.12	45.24	24.66	-
Cash Income Tax Paid	14.36	6.02	2.65	-	-
Levered Free Cash Flow	197.88	103.55	-444.35	97.11	-777.14
Unlevered Free Cash Flow	286.54	179.32	-346.87	186.5	-724.33
Change in Net Working Capital	-102.62	-142.15	59.25	-450.37	350.5

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.